Floatz logo

Gadobutrol

Stage I-IV Breast Cancer (Neo-adjuvant, Adjuvant, Locally Advanced and Metastatic)

Unity Health TorontoSmall moleculeDormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Stage I-IV Breast Cancer (Neo-adjuvant, Adjuvant, Locally Advanced and Metastatic) cohort.

Asset / SponsorPhaseRating

Same molecule, other indications

Gadobutrol is also rated in:

cognitive disorderDormant
BB
Indicative ·
65 / 100
View asset →
Contrast MediaDormant
BB
Indicative ·
65 / 100
View asset →
Magnetic Resonance ImagingDormant
BB
Indicative ·
64 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →